Ongoing phase II study of intravenous recombinant human anti-p185 HER2 monoclonal antibody 4D5 (MAb 4D5) in patients with stage IV breast cancer overexpressing HER2 Meeting Abstract
| Authors: | Baselga, J.; Tripathy, D.; Mendelsohn, J.; Benz, C.; Rosen, P. P.; Henderson, I. C.; Twaddell, T.; Norton, L. |
| Abstract Title: | Ongoing phase II study of intravenous recombinant human anti-p185 HER2 monoclonal antibody 4D5 (MAb 4D5) in patients with stage IV breast cancer overexpressing HER2 |
| Meeting Title: | 17th Annual San Antonio Breast Cancer Symposium |
| Keywords: | cancer therapy; immunotherapy; immunologic-drug; monoclonal antibody 4d5; meeting abstract; antineoplastic effect |
| Journal Title: | Breast Cancer Research and Treatment |
| Volume: | 32 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 1994 Dec 6-10 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0167-6806 |
| Publisher: | Springer |
| Date Published: | 1994-01-01 |
| Start Page: | 30 |
| Language: | English |
| ACCESSION: | BCI:BCI199598029353 |
| PROVIDER: | biosis |
| PUBMED: | 7865860 |
| DOI: | 10.1007/BF00665740 |
| Notes: | Meeting Abstract: 8 -- Source: Biosis |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
758Norton -
201Rosen -
484Baselga -
128Mendelsohn
Related MSK Work